Home›Neuroscience›Selection of Plasmodium falciparum Parasites for Cytoadhesion to Human Brain Endothelial Cells
NeuroscienceJoVE (Open Access)Citable · DOI
Selection of Plasmodium falciparum Parasites for Cytoadhesion to Human Brain Endothelial Cells
DOI: 10.3791/3122-v
What you'll learn
✓Culture Plasmodium falciparum parasites and human brain endothelial cells in vitro
✓Select P. falciparum for cytoadhesion phenotype using endothelial cell binding
✓Quantify increased parasite binding to endothelial cells after selection
Protocol
An in vitro model for cerebral malaria sequestration is described1. Plasmodium falciparum infected red blood cells are selected for binding to immortalized human brain microvascular endothelial cells. The selected parasites show a distinct phenotype. The selection process can be applied using various P. falciparum strains and endothelial cell lines.
Difficulty
advanced
Total time
~2–3 weeks (iterative selection cycles with continuous culture maintenance)
Model organism
Plasmodium falciparum, human brain microvascular endothelial cells (HBEC-5i)
Biosafety
BSL-2
Steps
1
Prepare and maintain Plasmodium falciparum culture
Culture P. falciparum parasites using standard protocols with routine media changes and maintenance to ensure viable parasitized red blood cells for selection.
▶ 01:14
2
Culture endothelial cells and prepare for selection
Maintain immortalized human brain microvascular endothelial cells (HBEC-5i) in culture and prepare monolayers as substrate for parasite binding experiments.
▶ 02:54
3
Select parasites for cytoadhesion to endothelial cells
Incubate P. falciparum-infected red blood cells with HBEC-5i monolayers to enrich for parasites with high binding affinity, then recover bound parasites through washing and culture.
▶ 04:00
4
Quantify increased binding after selection rounds
Measure and compare binding efficiency of selected parasites to HBEC-5i cells across selection iterations to confirm phenotypic enrichment.
▶ 07:36
💬 Comments coming soon
New protocols and pitfalls, in your inbox
A short email when we add notable lab videos and failure cases. No spam, unsubscribe anytime.